Texas NOFR002: Prescription Drug Prior Authorization

Texas health plans that require prior authorization of a prescription drug or device must accept this standard request, which prescribers fax or mail to the plan or its PBM. Besides prior authorization, it covers formulary exceptions, quantity limit overrides and step-therapy exceptions. Commercial issuers, Medicaid and its managed care plans, CHIP, and state employee, school district, UT and Texas A&M plans all must take it.

Who completes it

The prescriber or the prescriber's office completes Sections II through IX. Section I names the issuer or its pharmacy benefit agent and may already be filled in on the copy posted on the issuer's website; the Section II signature line is for the prescriber or the prescriber's designee.

How to fill it in

Section I: Submission

Enter the name, phone, fax and date for the issuer, or for the agent that manages or administers its prescription drug benefits. An issuer or agent may have prepopulated its contact information on the copy posted on its website, so start from the plan's own copy when one exists. This tells you where to fax or mail the request.

Section II: Review

Check Expedited/Urgent Review Requested only when applying the standard review time frame may seriously jeopardize the patient's life, health or ability to regain maximum function. Checking the box takes the signature and date of the prescriber or the prescriber's designee, which certifies that statement. Leave the box unchecked for routine requests.

Section III: Patient Information

Enter the patient's name, phone, date of birth and sex (Male, Female, Other or Unknown), plus street address, city, state and ZIP code. If the issuer differs from the one named in Section I, give its name here. Add the member or Medicaid ID number and the group number so the issuer can match the request to the right coverage.

Section IV: Prescriber Information

Give the prescriber's name, NPI, specialty, address, phone and fax, and the office contact name and contact phone. The issuer uses these details to reach the office with questions and to return its decision, so list a fax line and contact person who can respond during the review period.

Section V: Prescription Drug Information

Enter the requested drug name, strength, route, quantity, days' supply and expected therapy duration. Mark new therapy or continuation, with the approximate start date, and for continuation confirm adherence and effectiveness. For provider-administered drugs, add the HCPCS code, NDC and dose per administration. For a compound drug, list all ingredients in Section VI instead of here.

Section VI: Prescription Compound Drug Information

Name the compound and list each ingredient with its NDC number and quantity. The instructions require quantities in units of measure such as mg or ml, so write the unit with every amount. Complete this section only when the request is for a compound; a single-ingredient drug is fully described in Section V.

Section VII: Prescription Device Information

For a prescription device, enter the requested device name, the expected duration of use and, if applicable, its HCPCS code. Issuers that require prior authorization of a prescription device must accept this form for it, so a device request does not need a separate service form such as NOFR001.

Section VIII: Patient Clinical Information

Give the diagnosis related to the request with the current ICD version and code. List drugs the patient has taken for this diagnosis with strength, frequency, dates started and stopped or approximate duration, and the response, reason for failure or allergy. Add height and weight if applicable, drug allergies, and relevant laboratory values with dates, or attach them.

Section IX: Justification

In the space or on a separate page, provide clinical information justifying initial or ongoing therapy or an increase in dosage, strength or frequency. Explain comorbid conditions and contraindications to formulary drugs, give titration regimens or oncology staging if applicable, and give the details for any step-therapy exception under Insurance Code Section 1369.0546(c). Attach medical records, progress notes or lab reports if needed.

Common mistakes

  • Sending the form to the Texas Department of Insurance, the Health and Human Services Commission or the patient's employer instead of the issuer.
  • Using NOFR002 to appeal, confirm eligibility, verify coverage, request a payment guarantee or ask whether a drug needs prior authorization; the instructions exclude all of these.
  • Skipping Section IX on a step-therapy exception request; it must be completed even when the request is for continuation of therapy.
  • Listing compound ingredient quantities without units of measure such as mg or ml in Section VI.
  • Leaving out the ICD version in Section VIII; the instructions ask for the current ICD version alongside the diagnosis code.
  • Not checking the issuer's website first; some issuers require more information or additional forms to process the request.

Submitting and payment

How to submit it
Fax or mail it to the issuer, or the agent that administers its drug benefits, named in Section I; an issuer may also post an electronic version to complete through its portal. Do not send it to TDI, the Texas Health and Human Services Commission or the patient's employer.
Who pays
The instructions bar using the form to request a guarantee of payment, verify coverage or confirm eligibility.

Good to know

  • Issuers must accept it under TDI rule 28 TAC Section 19.1820 whenever their plan requires prior authorization of a prescription drug or device.
  • For a health care service rather than a drug or device, use the companion form NOFR001. Neither form can be used to file an appeal.
  • For continuation of therapy, Sections VIII and IX can be skipped unless information has materially changed, except for a step-therapy exception, which always needs Section IX.
  • The current version is coded NOFR002 | 0522 and runs three pages: one page of instructions and two pages of request fields.

Get the official form

Download the current version from the source each time; forms change without notice.

Texas Standard Prior Authorization Request Form for Prescription Drug Benefits

How this list is checked

A form is listed only after its name and number were confirmed on the issuing agency’s or insurer’s own website, or in the form itself. Each entry links to that source. The list was last checked in October 2026. Forms and their requirements change without notice, so check the official page for the current version before you complete one.

Vero is not affiliated with, or endorsed by, the agencies and insurers listed here. Read our editorial policy.

Frequently asked questions

Do Texas Medicaid and CHIP plans accept NOFR002?

Yes. Besides commercial issuers, the form lists Medicaid, the Medicaid managed care program, CHIP, and plans covering employees of the state of Texas, most school districts, and The University of Texas and Texas A&M Systems as issuers that must accept it when they require prior authorization of a prescription drug or device.

Can I use NOFR002 to appeal a denied prescription?

No. The instructions list six things the form is not for: requesting an appeal, confirming eligibility, verifying coverage, requesting a guarantee of payment, asking whether a drug or device needs prior authorization, and requesting prior authorization of a health care service. Use the issuer's appeal process for a denial.

How do I request a step-therapy exception on the Texas form?

Complete Section IX, Justification, with pertinent information about the exception, citing the grounds in Texas Insurance Code Section 1369.0546(c). Section IX is required for a step-therapy exception even when the request is for continuation of therapy. Attach supporting records if needed.

Who signs the Texas prescription drug prior authorization form?

The only signature line is in Section II. The prescriber or the prescriber's designee checks the expedited or urgent review box, then signs and dates to certify that the standard review time frame may seriously jeopardize the patient's life, health or ability to regain maximum function.